The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ruth Matthew R. since 2021.
This trader's CIK number is 1872022.
At the time of last reporting, Ruth Matthew R. was the Chief Commercial Officer of Opiant Pharmaceuticals, Inc.. (stock ticker symbol OPNT).
Also see all insider trading activities at Opiant Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | OPNT | 0 | $0 | 1,084 | $11,512 | 0 | $0 |
| 2021 | OPNT | 2,000 | $34,680 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-20 | OPNT | Sale | 1,084 | 10.62 | 11,512 |
| 2021-08-31 | OPNT | Buy | 2,000 | 17.34 | 34,680 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ruth Matthew R. (Chief Commercial Officer of Opiant Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.